Joinn’s ‘jumping’ monkey market hides core weakness
Despite announcing a sharp profit surge, the lab animal provider’s stock ticked up by just a muted 3% over the next three trading days Key Takeaways: Joinn Laboratories has built…
Joinn Labs undermined by AI as FDA phases out animal drug testing
The outsourced clinical research services provider’s shares tumbled after the U.S. drug regulator announced a new approach to drug testing Key Takeaways: Joinn Labs’ shares fell on heavy trading as…
Recent Articles
Joinn’s ‘jumping’ monkey market hides core weakness
6127.HK
603127.SHG
Joinn Labs undermined by AI as FDA phases out animal drug testing
6127.HK
603127.SHG
